Correlation Engine 2.0
Clear Search sequence regions

  • and disease (1)
  • anion (17)
  • cellular (1)
  • humans (1)
  • layer (1)
  • level drug (1)
  • polypeptides (7)
  • Sizes of these terms reflect their relevance to your search.

    The organic anion transporters (OATs) and organic anion-transporting polypeptides (OATPs) belong to the solute carrier (SLC) transporter superfamily and play important roles in handling various endogenous and exogenous compounds of anionic charge. The OATs and OATPs are often implicated in drug therapy by impacting the pharmacokinetics of clinically important drugs and, thereby, drug exposure in the target organs or cells. Various mechanisms (e.g. genetic, environmental, and disease-related factors, drug-drug interactions, and food-drug interactions) can lead to variations in the expression and activity of the anion drug-transporting proteins of OATs and OATPs, possibly impacting the therapeutic outcomes. Previous investigations mainly focused on the regulation at the transcriptional level and drug-drug interactions as competing substrates or inhibitors. Recently, evidence has accumulated that cellular trafficking, post-translational modification, and degradation mechanisms serve as another important layer for the mechanisms underlying the variations in the OATs and OATPs. This review will provide a brief overview of the major OATs and OATPs implicated in drug therapy and summarize recent progress in our understanding of the post-translational modifications, in particular ubiquitination and degradation pathways of the individual OATs and OATPs implicated in drug therapy. © 2020 Lee et al.


    Wooin Lee, Jeong-Min Ha, Yuichi Sugiyama. Post-translational regulation of the major drug transporters in the families of organic anion transporters and organic anion-transporting polypeptides. The Journal of biological chemistry. 2020 Dec 11;295(50):17349-17364

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 33051208

    View Full Text